Rothschild & CO Asset Management Us Inc. Intercept Pharmaceuticals, Inc. Call Options Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICPT
# of Institutions
6Shares Held
1.04MCall Options Held
30KPut Options Held
5.9KAbout INTERCEPT PHARMACEUTICALS, INC.
- Ticker ICPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,127,400
- Description
- Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...